Globus Medical (GMED) Capital Expenditures Growth (1y) (2012 - 2026)
Globus Medical (GMED) Capital Expenditures Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn | -47.73% |
| 10 | Globus Medical | 10.62 Bn | 9.99 Bn | 525.79 Mn | 9.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.73% |
| Dec 31, 2025 | 151.89% |
| Sep 30, 2025 | 150.35% |
| Jun 30, 2025 | -181.48% |
| Mar 31, 2025 | 26.38% |
| Dec 31, 2024 | -489.13% |
| Sep 30, 2024 | 94.82% |
| Jun 30, 2024 | 1.58% |
| Mar 31, 2024 | 339.98% |
| Dec 31, 2023 | 24.76% |
| Sep 30, 2023 | 79.70% |
| Jun 30, 2023 | 15.21% |
| Mar 31, 2023 | -67.49% |
| Dec 31, 2022 | 7.60% |
| Sep 30, 2022 | -67.00% |
| Jun 30, 2022 | 2,490.29% |
| Mar 31, 2022 | 662.25% |
| Dec 31, 2021 | 21.20% |
| Sep 30, 2021 | -16.40% |
| Jun 30, 2021 | 5.65% |